Pailin Biotech (000403.SZ): Controlling shareholder plans to change to resume trading of China Biotech shares

Zhitongcaijing · 06/09 12:25

Zhitong Finance App News, Pailin Biotech (000403.SZ) announced that on June 8, 2025, China Biotechnology Co., Ltd. (“China Biotech”) signed an “Acquisition Framework Agreement” with Gongqingcheng Shengbang Yinghao Investment Partnership (Limited Partnership) (“Shengbang Yinghao”), the controlling shareholder of the company. Shengbang Yinghao plans to transfer 21.03% of the company's shares to China Biotech (“this transaction”).

If the transaction progresses smoothly and is implemented, the controlling shareholder of the company will be changed from Shengbang Yinghao to China Biotech, and the actual controller of the company will be changed from the State-owned Assets Supervision and Administration Committee of the Shaanxi Provincial People's Government to China Pharmaceutical Group Co., Ltd. Following the company's application, trading of the company's shares resumed from the opening of the market on June 10, 2025 (Tuesday).